GLP1R and Parkinson disease: .An experiment applied a second-generation novel GLP-1/GIP dual receptor agonist, DA3-CH, to an MPTP-induced Parkinson’s mouse model and compared its neuroprotective effects with the GLP-1 single receptor agonist, liraglutide.